Abstract
The AI era in medicine has ushered in new opportunities to improve the diagnosis and treatment of human disease. CHARM, an AI algorithm described in this issue,1 has the potential to streamline molecular classification, intraoperative diagnosis, surgical decision making, and trial enrollment for glioma patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have